Georgiamune, the US clinical-stage immunology biotech, has granted Stemline Therapeutics, the oncology subsidiary of Italy’s ...
Boston, USA-based AI Proteins, a biotech that uses computational de novo protein design to create therapeutic miniproteins, ...
Japan’s Shionogi and UK-based F2G Ltd today announced results from the global Phase III OASIS study, in a late-breaking oral ...
INmune Bio Inc, a late-stage biotechnology company focused on inflammation and immunology, today announced that it has ...
Pharma major Roche reported third-quarter 2026 group sales of 16.13 billion Swiss francs ($19.61 billion), up 7% at constant ...
Florida, USA-based biotech GOA Therapeutics has launched offerings totaling $300 million to fund the advancement of its drug ...
Enhertu (trastuzumab deruxtecan) has been approved in China as a monotherapy for the treatment of adult patients with ...
US healthcare giant Johnson & Johnson has announced new data that further expands the clinical evidence supporting Tremfya ...
Russian pharmaceutical manufacturers and global drugmakers operating in the local market have called on the need of ...
The US Food and Drug Administration (FDA) yesterday approved UK pharma major GSK’s Hibsago (bepirovirsen) injection, in ...
Florida, USA-based biotech GOA Therapeutics has launched offerings totaling $300 million to fund the advancement of its drug ...
US artificial intelligence (AI) company OpenAI has acquired Orchestra Bio, adding a platform for coordinating drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results